Sophrosyne Capital’s Cardiovascular Systems, Inc. CSII Stock Holding History

Sophrosyne Capital’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-48,400	Closed	-$1.89M	–	22
2015 Q1	$1.89M	Sell	48,400 -36,700	-43%	-$1.26M	3.24%	11
2014 Q4	$2.56M	Sell	85,100 -6,741	-7%	-$193K	3.95%	8
2014 Q3	$2.17M	Sell	91,841 -1,100	-1%	-$31.3K	2.56%	14
2014 Q2	$2.9M	Buy	92,941 +46,300	+99%	+$1.33M	2.95%	10
2014 Q1	$1.48M	Sell	46,641 -10,300	-18%	-$340K	1.3%	23
2013 Q4	$1.95M	Sell	56,941 -74,600	-57%	-$2.17M	1.71%	17
2013 Q3	$2.64M	Sell	131,541 -44,800	-25%	-$933K	1.74%	21
2013 Q2	$3.74M	Buy	+176,341	New	+$3.43M	2.93%	13

Other funds holding CSII

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sophrosyne Capital's CSII Position: Q2 2015 in Review

Sophrosyne Capital sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2015, closing a stake of 48,400 shares — an estimated $1.89M sold.

Sophrosyne Capital first reported a position in CSII in Q2 2013 and held it in 8 quarters. The position peaked at $3.74M in Q2 2013. 138 funds tracked by Wall St. Rank hold CSII as of Q2 2015.

Sophrosyne Capital reported no remaining Cardiovascular Systems, Inc. position as of Q2 2015 after selling out during the quarter.
Sophrosyne Capital sold 48,400 Cardiovascular Systems, Inc. shares in Q2 2015, an estimated $1.89M.
Sophrosyne Capital first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 8 quarters.
Sophrosyne Capital's Cardiovascular Systems, Inc. position peaked at $3.74M in Q2 2013.
138 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2015.

Based on Sophrosyne Capital's 13F filing for Q2 2015, filed 14 Aug 2015.